Year |
Citation |
Score |
2019 |
Jaggar M, Banerjee T, Weisstaub N, Gingrich JA, Vaidya VA. 5-HT receptor loss does not alter acute fluoxetine-induced anxiety and exhibit sex-dependent regulation of cortical immediate early gene expression. Neuronal Signaling. 3: NS20180205. PMID 32714597 DOI: 10.1042/NS20180205 |
0.507 |
|
2017 |
Jaggar M, Weisstaub N, Gingrich JA, Vaidya VA. 5-HT2A receptor deficiency alters the metabolic and transcriptional, but not the behavioral, consequences of chronic unpredictable stress. Neurobiology of Stress. 7: 89-102. PMID 28626787 DOI: 10.1016/J.Ynstr.2017.06.001 |
0.418 |
|
2015 |
Goitia B, Rivero-Echeto MC, Weisstaub NV, Gingrich JA, Garcia-Rill E, Bisagno V, Urbano FJ. Modulation of gaba release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors. Journal of Neurochemistry. PMID 26484945 DOI: 10.1111/Jnc.13398 |
0.368 |
|
2008 |
Lu R, Alioua A, Kumar Y, Kundu P, Eghbali M, Weisstaub NV, Gingrich JA, Stefani E, Toro L. c-Src tyrosine kinase, a critical component for 5-HT2A receptor-mediated contraction in rat aorta. The Journal of Physiology. 586: 3855-69. PMID 18599541 DOI: 10.1113/Jphysiol.2008.153593 |
0.396 |
|
2007 |
González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron. 53: 439-52. PMID 17270739 DOI: 10.1016/J.Neuron.2007.01.008 |
0.535 |
|
2006 |
Weisstaub NV, Zhou M, Lira A, Lambe E, González-Maeso J, Hornung JP, Sibille E, Underwood M, Itohara S, Dauer WT, Ansorge MS, Morelli E, Mann JJ, Toth M, Aghajanian G, et al. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science (New York, N.Y.). 313: 536-40. PMID 16873667 DOI: 10.1126/Science.1123432 |
0.64 |
|
2003 |
González-Maeso J, Yuen T, Ebersole BJ, Wurmbach E, Lira A, Zhou M, Weisstaub N, Hen R, Gingrich JA, Sealfon SC. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 8836-43. PMID 14523084 |
0.608 |
|
2003 |
Gingrich JA, Ansorge MS, Merker R, Weisstaub N, Zhou M. New lessons from knockout mice: The role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders. Cns Spectrums. 8: 572-7. PMID 12907920 |
0.552 |
|
2003 |
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (New York, N.Y.). 301: 805-9. PMID 12907793 DOI: 10.1126/Science.1083328 |
0.353 |
|
2003 |
González-Maeso J, Yuen T, Ebersole BJ, Wurmbach E, Lira A, Zhou M, Weisstaub N, Hen R, Gingrich JA, Sealfon SC. Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex The Journal of Neuroscience. 23: 8836-8843. DOI: 10.1523/Jneurosci.23-26-08836.2003 |
0.573 |
|
Show low-probability matches. |